Achieve Life Sciences Announces 2024 Annual Meeting of Stockholders

TL;DR

<b>Achieve Life Sciences will hold its virtual Annual Meeting of Stockholders on June 5, 2024, to elect directors and ratify auditors.</b>

AI Summary

ACHIEVE LIFE SCIENCES, INC. (ACHV) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Annual Meeting scheduled for June 5, 2024, at 8:00 a.m. Pacific time. Meeting will be a virtual stockholder meeting accessible via live webcast. Purpose includes election of eight directors. Purpose includes ratification of PricewaterhouseCoopers LLP as independent auditor for FY 2024. Stockholders of record as of April 10, 2024, are entitled to vote.

Why It Matters

For investors and stakeholders tracking ACHIEVE LIFE SCIENCES, INC., this filing contains several important signals. The election of directors is a standard governance procedure to ensure board oversight. Ratifying the independent auditor is crucial for financial transparency and investor confidence.

Risk Assessment

Risk Level: low — ACHIEVE LIFE SCIENCES, INC. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational information that would indicate significant risk.

Analyst Insight

Stockholders should review the director nominees and be prepared to vote on the ratification of the independent auditor.

Key Numbers

• 8 — Directors to be elected (To serve until the next annual meeting of stockholders.)
• 2024 — Fiscal Year End (For which PricewaterhouseCoopers LLP is being ratified as auditor.)

Key Players & Entities

• Achieve Life Sciences, Inc. (company) — Registrant
• June 5, 2024 (date) — Annual Meeting date
• PricewaterhouseCoopers LLP (company) — Independent registered public accounting firm
• April 10, 2024 (date) — Record date for voting
• John Bencich (person) — Chief Executive Officer

FAQ

Industry Context

Achieve Life Sciences operates in the biotechnology sector, focusing on developing therapies. This filing is a standard corporate governance document.

Regulatory Implications

The filing is made under Section 14(a) of the Securities Exchange Act of 1934, governing proxy solicitations.

What Investors Should Do

1. Review the biographies and qualifications of the director nominees.
2. Understand the proposal to ratify PricewaterhouseCoopers LLP as the independent auditor.
3. Ensure voting instructions are submitted by the deadline to participate in the virtual meeting.

Key Dates

• 2024-06-05: Annual Meeting of Stockholders — Election of directors and ratification of auditors.
• 2024-04-10: Record Date — Stockholders of record on this date are entitled to vote.
• 2024-04-26: Filing Date — Date the Definitive Proxy Statement was filed with the SEC.

Year-Over-Year Comparison

This is a DEF 14A filing for the annual meeting, indicating a routine corporate governance event rather than a change from a previous filing type.

Filing Documents

• achv_2024_proxy-def14a.htm (DEF 14A) — 921KB
• img185693128_0.jpg (GRAPHIC) — 22KB
• img185693128_1.jpg (GRAPHIC) — 152KB
• img185693128_2.jpg (GRAPHIC) — 150KB
• img185693128_3.jpg (GRAPHIC) — 22KB
• img185693128_4.jpg (GRAPHIC) — 540KB
• img185693128_5.jpg (GRAPHIC) — 422KB
• 0000950170-24-049089.txt (&nbsp;) — 2723KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 22

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 32 OTHER MATTERS 34 ACHIEVE LIFE SCIENCES, INC. 22722 29 th Drive SE, Suite 100 Bothell, WA 98021 1040 West Georgia, Suite 1030 Vancouver, BC, Canada PROXY STATEMENT FOR 2024 ANNUAL MEETING OF STOCKHOLDERS This proxy statement, or Proxy Statement, is furnished in connection with the solicitation of proxies on behalf of the board of directors, or Board of Directors or Board, of Achieve Life Sciences, Inc., a Delaware corporation, or the Company or Achieve, for use at the Annual Meeting of Stockholders, or the Annual Meeting, to be held on June 5, 2024, at 8:00 a.m. Pacific time for the purposes set forth in this Proxy Statement and in the accompanying Notice of Annual Meeting. We believe that a virtual stockholder meeting provides greater access to those who may want to attend, and therefore we have chosen that the Annual Meeting be held by virtual meeting. This approach also lowers costs and aligns with our broader sustainability goals. To be admitted virtually to the Annual Meeting at www.virtualshareholdermeeting.com/ACHV2024 , you must enter the control number found on your proxy card, voting instruction form or notice you previously received. You may vote during the Annual Meeting by following the instructions available on the meeting website during the Annual Meeting. This Notice of the Annual Meeting, Proxy Statement, form of proxy and Annual Report on Form 10-K for the year ended December 31, 2023 will first be mailed on or about April 26, 2024 to all stockholders entitled to vote at the Annual Meeting. Voting Rights Only stockholders of record at the close of business on April 10, 2024, the record date, are entitled to notice of and to vote at the Annual Meeting and any adjournment or postponement of the Annual Meeting. At the close of business on April 10, 2024, we had 34,251,911 shares of common stock outstanding. Each stockholder of record is entitled to one vot

View Full Filing

View this DEF 14A filing on SEC EDGAR